Investors
Engage with the leading edge of biopharmaceuticals

Overview

With outstanding potential to increase survivability and reduce the extensive medical and societal costs associated with cancer world-wide, there is much interest in developing BXQ-350 as rapidly as possible.

As such this is an exciting time and opportunity for new partnerships and investments to attain this goal.

Investors